Could a 4-Week steroid course be safer for vasculitis patients?
NCT ID NCT06983821
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial is testing whether a 4-week low-dose steroid regimen, given alongside standard drugs like rituximab or cyclophosphamide, is safer and as effective as the usual longer steroid treatment for ANCA vasculitis with severe kidney problems. The study will enroll 36 people with newly diagnosed or relapsed disease. The goal is to reduce serious infections while still controlling the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Prednisone (a steroid) given with standard drugs like rituximab or cyclophosphamide
What this could lead to
If successful, this could lead to a safer, shorter steroid treatment for ANCA vasculitis, reducing serious infections while still controlling the disease.
What could go wrong
This is a small pilot phase (36 participants) testing feasibility, so results may not apply broadly. The low steroid dose might not control the disease as well as standard care, risking relapse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRANULOMATOSIS WITH POLYANGIITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
St-Joseph's Hospital
NOT_YET_RECRUITINGHamilton, Ontario, Canada
-
The Ottawa Hospital
RECRUITINGOttawa, Ontario, Canada